For over a decade, industry watchdogs, patient groups and various lawmakers have been calling for drug pricing reform—initially with...
A Fresh Take
Insights on M&A, litigation, and corporate governance in the US.
The 41st Annual J.P. Morgan Healthcare Conference, held in-person for the first time in three years, was a tale of two cities – marked...